A robotic system for cleaning surfaces to prevent virus spread
An Engineered Robotic Plasma Array for Large Area Surface Decontamination
This study is testing a new robot that uses special technology to clean surfaces in hospitals and clinics, helping to kill germs like the virus that causes COVID-19, so that these places can be safer for everyone.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boise State University NIH-funded |
| Lab location | 1 site (Boise, United States) |
| Project ID | NIH-10194138 on NIH RePORTER |
What this research studies
This research investigates a novel robotic plasma array designed to decontaminate large surface areas in medical facilities, targeting pathogens like SARS-CoV-2 and other infectious agents. The approach utilizes cold atmospheric-pressure plasma (CAP) technology, which has shown promise in inactivating bacteria and is being explored for its antiviral properties. By automating the decontamination process, the research aims to reduce the reliance on traditional cleaning methods that consume significant resources and time. This could lead to safer environments in hospitals and clinics, minimizing the risk of disease transmission through contaminated surfaces.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients receiving care in medical facilities where surface contamination poses a risk of infection.
Not a fit: Patients who are not in healthcare settings or those who do not have a risk of exposure to infectious diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance infection control in healthcare settings, reducing the spread of infectious diseases.
How similar studies have performed: Previous studies have shown that cold atmospheric-pressure plasma can effectively inactivate bacterial pathogens, but its application for viral decontamination is still being explored.
Where this research is happening
Boise, United States
- Boise State University — Boise, United States (Active)
Researchers
- Principal investigator: Browning, Jim — Boise State University
- Study coordinator: Browning, Jim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.